TY - JOUR
T1 - Corneal Toxicity Associated With Aquarium Coral Palytoxin
AU - Farooq, Asim V.
AU - Gibbons, Allister G.
AU - Council, Matthew D.
AU - Harocopos, George J.
AU - Holland, Simon
AU - Judelson, Jeffrey
AU - Shoss, Bradley L.
AU - Schmidt, Eric J.
AU - Md Noh, Umi Kalthum
AU - D'Angelo, Alexander
AU - Chundury, Rao V.
AU - Judelson, Richard
AU - Perez, Victor L.
AU - Huang, Andrew J.W.
N1 - Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2017/2/1
Y1 - 2017/2/1
N2 - Purpose To report a series of patients who developed corneal toxicity after exposure to aquarium coral palytoxin. Design Multicenter retrospective case series. Methods Retrospective review. Results Seven patients presented with corneal findings ranging from superficial punctate epitheliopathy to bilateral corneal melt with subsequent perforation. Among those with mild corneal findings, resolution was achieved with topical steroids and lubrication, whereas some patients who developed progressive corneal melt required therapeutic penetrating keratoplasty. The history in all patients revealed exposure to aquarium zoanthid corals shortly before disease onset. A review of the literature revealed that there are few prior reports of coral-associated corneal toxicity and that some species of coral secrete a substance known as palytoxin, a potent vasoconstrictor that inhibits the membranous sodium-potassium ATPase pump across cell types and can cause rapid death if inhaled or ingested. Conclusions This is the largest case series to date demonstrating patients with aquarium coral palytoxin–associated corneal toxicity, and is the first to provide details of related histopathologic findings. Similar to other forms of toxic keratoconjunctivitis, a detailed history and careful clinical assessment are required, as well as timely removal of the offending agent from the patients' ocular milieu and environment. Mild ocular surface and corneal disease may be treated effectively with aggressive topical steroid therapy and lubrication. Given the potential severity of ocular as well as systemic adverse effects, there should be increased awareness of this entity among eye care professionals, aquarium enthusiasts, and the general public.
AB - Purpose To report a series of patients who developed corneal toxicity after exposure to aquarium coral palytoxin. Design Multicenter retrospective case series. Methods Retrospective review. Results Seven patients presented with corneal findings ranging from superficial punctate epitheliopathy to bilateral corneal melt with subsequent perforation. Among those with mild corneal findings, resolution was achieved with topical steroids and lubrication, whereas some patients who developed progressive corneal melt required therapeutic penetrating keratoplasty. The history in all patients revealed exposure to aquarium zoanthid corals shortly before disease onset. A review of the literature revealed that there are few prior reports of coral-associated corneal toxicity and that some species of coral secrete a substance known as palytoxin, a potent vasoconstrictor that inhibits the membranous sodium-potassium ATPase pump across cell types and can cause rapid death if inhaled or ingested. Conclusions This is the largest case series to date demonstrating patients with aquarium coral palytoxin–associated corneal toxicity, and is the first to provide details of related histopathologic findings. Similar to other forms of toxic keratoconjunctivitis, a detailed history and careful clinical assessment are required, as well as timely removal of the offending agent from the patients' ocular milieu and environment. Mild ocular surface and corneal disease may be treated effectively with aggressive topical steroid therapy and lubrication. Given the potential severity of ocular as well as systemic adverse effects, there should be increased awareness of this entity among eye care professionals, aquarium enthusiasts, and the general public.
UR - http://www.scopus.com/inward/record.url?scp=85003864985&partnerID=8YFLogxK
U2 - 10.1016/j.ajo.2016.10.007
DO - 10.1016/j.ajo.2016.10.007
M3 - Article
C2 - 27793603
AN - SCOPUS:85003864985
SN - 0002-9394
VL - 174
SP - 119
EP - 125
JO - American journal of ophthalmology
JF - American journal of ophthalmology
ER -